|
Market Closed -
Nasdaq
02:30:00 04/11/2026 am IST
|
Pre-market 06:33:10 pm | |||
| 167.47 USD | -1.68% |
|
174.18 | +4.01% |
| 04:07pm | DZ Bank Adjusts Price Target on Gilead Sciences to $191 From $167 | MT |
| 02/11 | Dr Reddy's gets tentative US FDA nod for generic HIV prevention | RE |
| Market Cap | 21TCr 19TCr 17TCr 15TCr 29TCr 19,67700Cr 30TCr 2,03500Cr 82TCr 10,38500Cr 78TCr 76TCr 32,91700Cr | P/E 2026 * |
-40.1x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 23TCr 20TCr 19TCr 17TCr 32TCr 21,69200Cr 33TCr 2,24300Cr 90TCr 11,44900Cr 86TCr 84TCr 36,28800Cr | EV / Sales 2026 * |
7.32x | EV / Sales 2027 * | 6.54x |
| Free-Float |
99.86% | Yield 2026 * |
1.97% | Yield 2027 * | 2.01% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
Tradegate
| GIS | Real-time | |
Mexican S.E.
| GILD * | End-of-day quote | |
Xetra
| GIS | Delayed | |
Boerse Muenchen
| GIS | Real-time | |
Deutsche Boerse AG
| GIS | Delayed | |
Wiener Boerse
| GILD | End-of-day quote | |
Börse Stuttgart
| GIS | Delayed | |
CBOE
| Real-time | ||
Borsa Italiana
| 1GILD | End-of-day quote | |
London S.E.
| 0QYQ | Delayed | |
Santiago S.E.
| GILD | End-of-day quote | |
Swiss Exchange
| GILD | Delayed | |
Lima
| GILDUS | End-of-day quote | |
Santiago S.E.
| GILDCL | End-of-day quote | |
Swiss Exchange
| GILD | Delayed | |
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.68% | ||
| 1 week | +5.27% | ||
| Current month | -1.88% | ||
| 1 month | +15.70% | ||
| 3 months | +27.69% | ||
| 6 months | +27.21% | ||
| Current year | +36.44% |
| 1 week | 160.86 | 175.65 | |
| 1 month | 142.6 | 175.65 | |
| Current year | 116.88 | 175.65 | |
| 1 year | 116.88 | 175.65 | |
| 3 years | 62.07 | 175.65 | |
| 5 years | 57.16 | 175.65 | |
| 10 years | 56.56 | 175.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/10/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 15/10/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 01/10/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.68% | +5.27% | +37.21% | +105.26% | 21TCr | ||
| -0.11% | +9.94% | +57.20% | +148.21% | 1,25500Cr | ||
| -1.62% | -0.95% | +42.90% | +75.88% | 64TCr | ||
| -0.98% | -0.14% | +34.93% | +102.23% | 51TCr | ||
| +0.64% | -1.55% | +48.71% | +65.55% | 38TCr | ||
| -2.49% | +2.01% | +75.38% | +39.94% | 36TCr | ||
| +1.54% | +3.20% | +31.42% | +58.31% | 30TCr | ||
| +1.36% | +8.87% | +10.92% | +35.23% | 29TCr | ||
| -0.90% | +2.97% | +55.67% | +70.93% | 25TCr | ||
| +5.08% | +11.63% | -9.69% | -59.40% | 18TCr | ||
| Average | +1.46% | +3.06% | +38.47% | +64.21% | 43.64TCr | |
| Weighted average by Cap. | +1.79% | +3.91% | +44.67% | +87.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13TCr 2.8TCr 2.57TCr 2.33TCr 4.38TCr 2,96400Cr 4.49TCr 31TCr 12TCr 1,56400Cr 12TCr 11TCr 4,95800Cr | 3.35TCr 3TCr 2.75TCr 2.5TCr 4.7TCr 3,17800Cr 4.81TCr 33TCr 13TCr 1,67700Cr 13TCr 12TCr 5,31700Cr |
| Net income | -509.06Cr -454.8Cr -417.76Cr -379.41Cr -712.5Cr -48TCr -730.4Cr -4.99TCr -2.01TCr -25TCr -1.91TCr -1.87TCr -81TCr | 1.06TCr 947.71Cr 870.53Cr 790.62Cr 1.48TCr 1,00500Cr 1.52TCr 10TCr 4.18TCr 53TCr 3.98TCr 3.9TCr 1,68100Cr |
| Net Debt | 2.13TCr 1.9TCr 1.75TCr 1.59TCr 2.98TCr 2,01500Cr 3.05TCr 21TCr 8.38TCr 1,06400Cr 7.98TCr 7.81TCr 3,37100Cr | 1.16TCr 1.04TCr 952.9Cr 865.43Cr 1.63TCr 1,10000Cr 1.67TCr 11TCr 4.58TCr 58TCr 4.36TCr 4.27TCr 1,84000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $167.47 | -1.68% | 66,06,702 |
| 02/26/02 | $170.33 | -0.21% | 88,76,067 |
| 30/26/30 | $170.68 | +3.06% | 1,14,27,256 |
| 29/26/29 | $165.61 | +4.03% | 84,31,613 |
| 28/26/28 | $159.20 | +0.08% | 50,02,342 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions


















